International Publications, Speeches, and News
Image
Connect with us: Follow @FDA_Global on X (formerly known as Twitter)
Publications
From a Global Perspective – Occasional thought pieces on international topics from experts across the FDA and interviews with global public health leaders.
Global Update – Global news, information, events, and resources from the FDA Office of Global Policy and Strategy
Speeches
- Remarks by Associate Commissioner Mark Abdoo at the DIA Roundtable, December 19, 2024
- Remarks by Deputy Commissioner for Policy, Legislation, and International Affairs Kimberlee Trzeciak at 19th Annual International Conference of Drug Regulatory Authorities, New Delhi, India, October 16, 2024
- Remarks by Associate Commissioner Mark Abdoo at the United States-Sub-Saharan Africa Trade and Economic Cooperation Forum, July 25, 2024
- Remarks by Associate Commissioner Mark Abdoo at the USP Convention Africa First Chapter Meeting, June 13, 2024
- Remarks by Associate Commissioner Mark Abdoo at the 25th Session of the International Medical Device Regulatory Forum, March 12, 2024
- Remarks by Deputy Commissioner for Policy, Legislation, and International Affairs Andi Fristedt at Peking University, Beijing, China, June 14, 2023
- Remarks by Associate Commissioner Mark Abdoo at the International Bar Association World Life Sciences Conference, June 1, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Food & Drug Law Institute 2023 Conference, May 18, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Asia-Pacific Economic Cooperation Medical Product Supply Chain Dialogue, April 25, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Indian Society for Clinical Research 16th Annual Meeting, February 24, 2023
- Remarks by Associate Commissioner Mark Abdoo at the Parenteral Drug Association India Chapter 10th Annual Meeting, February 21, 2023
- Remarks by Associate Commissioner Mark Abdoo at the MDSAP Forum, December 1, 2022
- Remarks of Mark Abdoo at the Winston and Strawn Healthcare and Life Sciences Summit 2022, May 21, 2022
- Presentation by Bruce Ross for the APHA's 2020 Virtual Annual Meeting, HHS's Global Health Workforce – On the Front Lines of Health Diplomacy During the Time of COVID-19, October 26, 2020
- Testimony by Mark Abdoo, Associate Commissioner for Global Policy and Strategy before the U.S.-China Economic & Security Review Commission, July 30, 2019
- Remarks by Mark Abdoo at the Opening Plenary Session, Drug Information Association (DIA) China Annual Meeting, May 21, 2019
- Remarks by Mark Abdoo at the AFDO 2018 Conference, International and Government Relations Committee Meeting, June 9, 2018
FDA International News
- OGPS Statement: FDA and African Medicines Agency Sign Historic Statement of Cooperation, June 17, 2026
- OGPS Statement: FDA and MHRA Establish Reciprocal Staff-Sharing Initiative, June 15, 2026
- World AIDS Day Feature, HIV/AIDS Research Pioneer Doug Shaffer Recounts Success Stories from Africa, December 1, 2024
- FDA Announces Withdrawal from Global Harmonization Working Party, CDRH Statement, November 27, 2023
- FDA Officials Meet with South African Health Products Regulatory Authority Delegation, OGPS Statement, August 29, 2023
- FDA Signs Shrimp Regulatory Partnership Agreement with Ecuador, OGPS Statement, August 25, 2023
- FDA Mutual Recognition Agreement with Swissmedic Enters Into Force, OGPS Statement, July 27, 2023
- FDA Signs Confidentially Commitment with Indonesia, OGPS Statement, July 10, 2023
- U.S. and India Cooperate on “Operation Broader Sword” to Stop International Shipments of Illegal and Dangerous Drugs, U.S. Embassy & Consulates in India Press Release, July 7, 2023
- FDA Expands Mutual Recognition Agreement with European Union, OGPS Statement, May 31, 2023
- Japanese Officials Meet with FDA to Discuss Future Collaborations, OGPS Statement, May 9, 2023
- Xinjiang Uyghur Autonomous Region of the People's Republic China, OGPS Statement, April 12, 2023
- FDA Officials Meet with Delegation from Nigeria, OGPS Statement, April 4, 2023
- FDA Officials Meet with Representatives of Mexico’s National Service of Agro-Alimentary Health, Safety and Quality (SENASICA), OGPS Statement, March 28, 2023 [Spanish translation]
- South Korean Health Officials Meet with FDA to Discuss Future Collaborations, OGPS Statement, March 21, 2023
- Danish Minister of Health and Danish Medicines Agency Meet with FDA to Discuss Future Collaborations, OGPS Statement, March 10, 2023
- FDA Agreement on Mutual Recognition between the Swiss Confederation and the United States of America Relating to Pharmaceutical Good Manufacturing Practice, OGPS Statement, January 12, 2023
- OGPS Leadership Message on Local Employed Staff Appreciation Day, OGPS Statement, November 16, 2022
- FDA Signs Confidentiality Commitment with Ecuador, OGPS Statement, August 18, 2022 [Spanish translation]
- FDA Meets with European Food and Drug Regulators, OGPS Statement, July 8, 2022
- Brazilian Health Regulatory Agency Meets with FDA to Discuss Medical Product Issues, OGPS Statement, May 18, 2022
- Meeting of Officials of the U.S. Food and Drug Administration and the German Federal Institute for Risk Assessment, OGPS Statement, May 9, 2022
U.S. Government Documents of International Interest
- Joint Update by the Department of State and the Department of Health and Human Services on Negotiations Toward a Pandemic Accord
- Letter Exchange Involving Aspartame